Lazdunski
Michael Lazdunski, Nice FR
Patent application number | Description | Published |
---|---|---|
20110250183 | Combination Therapy for Treatment of Patients with Neurological Disorders and Cerebral Infarction - The present invention provides compositions and methods for treating stroke patients using TCM and a Western medicament used for the treatment of stroke patients. | 10-13-2011 |
20140369995 | COMBINATION THERAPY FOR TREATMENT OF PATIENTS WITH NEUROLOGICAL DISORDERS AND CEREBRAL INFARCTION - The present invention provides compositions and methods for treating stroke patients using TCM and a Western medicament used for the treatment of stroke patients. | 12-18-2014 |
Michel Lazdunski, Nice FR
Patent application number | Description | Published |
---|---|---|
20090162368 | MECHANOSENSITIVE MAMMALIAN POTASSIUM CHANNEL ACTIVATABLE BY POLYUNSATURATED FATTY ACIDS - A purified protein comprising a mechanosensitive potassium channel activated by at least one polyunsaturated fatty acid and riluzole and the use of said channels in drug screening. | 06-25-2009 |
20110152197 | ANALGESIC EFFECTS OF PEPTIDE TOXIN APETX2 - The invention relates to the use of the peptide toxin APETx2 that blocks the ASIC3 cationic channels and that is derived from the | 06-23-2011 |
20120183580 | Analgesic Composition for Transbuccal Administration - The present invention relates to a pharmaceutical composition comprising a peptide of 5 to 50 amino acids which comprises the amino acid sequence NPFPTX | 07-19-2012 |
20120260354 | Use of K2P Potassium Channel Activators as Antalgics - The present invention relates to treating and preventing pain. More particularly the present invention demonstrates the involvement of K2P potassium channels in the antalgic effect of morphine. The present invention therefore provides a screening method for identifying antalgics. | 10-11-2012 |
20130064775 | USE OF RILUZOLE FOR TREATING OR PREVENTING THE ADVERSE EFFECTS OF ANTINEOPLASTIC AGENTS - This invention relates to riluzole for use in the treatment or prevention of adverse effects associated with the administration of anticancer agents having neurotoxic effects, such as, for example, platinum salts, taxanes and periwinkle alkaloids. | 03-14-2013 |
20130196923 | NOVEL PEPTIDES WHICH HAVE ANALGESIC EFFECTS AND WHICH INHIBIT ASIC CHANNELS - The present invention relates to novel isolated peptides which induce analgesia and which inhibit ASIC channels (Acid Sensing Ion Channels), to the polynucleotides encoding said peptides, and also to the pharmaceutical compositions, host cells and vectors comprising same. In particular, said peptides are isolated from the venom of the snake | 08-01-2013 |
20130287870 | NOVEL USES FOR TRADITIONAL CHINESE MEDICINE - The present invention relates to the use of one or more Neuroaid2 components to activate K | 10-31-2013 |
Michel Lazdunski, Colombo FR
Patent application number | Description | Published |
---|---|---|
20120040909 | IDENTIFICATION OF NOVEL ANTAGONIST TOXINS OF T-TYPE CALCIUM CHANNEL FOR ANALGESIC PURPOSES - A peptide with the following sequence YCQKFLWTCDSERPCCEGLVCRLWCKIN (SEQ ID NO 1) or a derivative thereof, and nucleic acids coding for the peptide having the sequence (SEQ ID NO 1). Also the use of this peptide as an antagonist and/or reverse agonist of T-type calcium channels. A use of the peptide for preparing a drug, in particular an analgesic one. | 02-16-2012 |
Michel Maurice Jacques Lazdunski, Nice FR
Patent application number | Description | Published |
---|---|---|
20120070407 | Therapy for Promoting Cell Growth - There is disclosed the use of a composition for promoting neuronal growth of neurons in tissues of the central or peripheral nervous system. There is also disclosed a method for inducing proliferation or differentiation of neuronal cells. | 03-22-2012 |